翰思艾泰生物医药科技（武汉）股份有限公司（03378）8月5日发布公告称，公司董事会会议将于2026年8月17日（星期一）举行，拟审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其发布事宜，并处理其他事项。
公告显示，截至公告日，公司董事会成员包括： 1. 执行董事：张发明博士、李其翔博士、肖婕妤女士、刘敏先生； 2. 非执行董事：李健博士； 3. 独立非执行董事：毕红钢博士、陈奇峰先生、王世雄先生、张瓊光博士。
此次董事会会议结果及中期业绩公布时间表，须以公司后续公告为准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.